Skip to content

Xencor XNCR Other Non-Current Liabilities

Other Non-Current Liabilities at other companies

Amgen logo
AmgenAMGN
$2.37B+7.0%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$2.13B+27.0%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$11.32M+597%
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
$3.25M
Absci Corporation logo
Absci CorporationABSI
$806K-52.2%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$0-100%

Other financials

Income statement

See full
Revenue$4.5M-86.2%
Operating income-$77.9M-80.3%
Net income-$128.9M-166%
EPS (diluted)-$1.71-159%

Balance sheet

See full
Cash & equivalents$14.2M-64.3%
Total debt$175.2M-21.2%
Total equity$515.6M-19.4%
Total assets$736.8M-18.6%

Cash flow

See full
Operating cash flow-$67.6M-317%
CapEx$610.0K-57.8%
Free cash flow-$68.2M-286%

Valuation

See full
Market cap$1.09B+79.8%
Enterprise value$1.25B+58.6%
P/S11.2×+6.4×

Profitability

See full
Operating margin-217.9%+425pp
Net margin-177.1%+16.5pp
FCF margin-194%+166pp

Returns & leverage

See full
Return on equity-29.8%-2.7pp
Debt / equity0.3×0.0×
Current ratio6.6×+0.7×

Where this comes from

Reported directly by Xencor in its filing.

Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.

The official record: Xencor’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xencor's other non-current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Xencor's other non-current liabilities?
Xencor (XNCR) reported other non-current liabilities of $152K in Q1 2026.
What does other non-current liabilities mean?
Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.